Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR4E.L Regulatory News (R4E)

  • There is currently no data for R4E

Trading on PLUS Markets

3 Apr 2008 07:00

First Artist Corporation PLC03 April 2008 Date: 3rd April 2008 On behalf of: First Artist Corporation Plc ('First Artist' or the 'Company') Embargoed for: 0700hrs First Artist Corporation plc Trading on PLUS Markets First Artist Corporation plc (AIM: FAN) ("the Company") is pleased to announcethat its ordinary shares have been admitted to trading on PLUS Markets witheffect from 3rd April 2008. The trading symbol on PLUS Markets will be "FAN",the same as on AIM. PLUS Markets is an independent London-based equity market, provided by PLUSMarkets Group plc, which was recently approved as a Recognised InvestmentExchange. PLUS Markets is based on a quote-driven trading system and currentlytrades all London-listed shares including the FTSE 100 and unlisted sharesquoted on the AIM and PLUS markets. The Company's ordinary shares will continue to be quoted and traded on AIM.Trading through PLUS is intended to enhance investor choice, improve liquidityfor shareholders and provide greater access to investors. For further information: First Artist Corporation plc tel: +44 (0)20 7993 0000 Richard Hughes, Group Managing DirectorJulianne Coutts, Company Secretary Redleaf Communications tel: +44 (0)20 7822 0200 Emma Kane / Samantha Robbins / Sanna Lehtinen Dawnay, Day Corporate Finance Limited tel: +44 (0)20 7509 4570 David Floyd, Nominated Adviser Daniel Stewart & Company plc tel: +44 (0)20 7776 6550 Katie Shelton This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Sep 20177:00 amRNSHalf-year Report
18th Sep 20177:00 amRNSDirectorate Change
31st Aug 20171:52 pmRNSTrading Update
20th Jul 20177:00 amRNSUpdate on debt facilities with PNC
29th Jun 20175:30 pmRNSPDMR Shareholding
27th Jun 201712:43 pmRNSResult of AGM
23rd Jun 201710:45 amRNSDirectorate Change
26th Apr 20177:00 amRNSFinal Results
3rd Apr 20172:30 pmRNSBanking update
28th Feb 201712:10 pmRNSDirector Declaration
24th Jan 20177:00 amRNSTrading Update and Directorate Changes
4th Jan 201710:46 amRNSHolding(s) in Company
30th Dec 20169:00 amRNSTotal Voting Rights
29th Dec 20164:00 pmRNSHolding(s) in Company
22nd Dec 20167:00 amRNSBanking update
21st Dec 20165:18 pmRNSIssue of equity, PDMR dealing and TVR
7th Dec 20165:21 pmRNSHolding(s) in Company
30th Nov 20165:30 pmRNSTotal Voting Rights
18th Nov 20165:55 pmRNSHolding(s) in Company
15th Nov 20169:45 amRNSHolding(s) in Company
7th Nov 201611:15 amRNSHolding(s) in Company
1st Nov 201611:11 amRNSHolding(s) in Company
26th Oct 20165:38 pmRNSCompletion of placing and director/PDMR dealing
26th Oct 201612:12 pmRNSProposed placing
14th Sep 20162:00 pmRNSNew German Subsidiary
12th Sep 20167:00 amRNSHalf-year Report
26th Jul 20162:06 pmRNSHolding(s) in Company
29th Jun 20161:30 pmRNSResult of AGM
29th Jun 20167:00 amRNSAGM Statement
22nd Jun 20169:30 amRNSDirector Disclosure Update
25th May 20167:00 amRNSFinal Results
19th May 20163:40 pmRNSHolding(s) in Company
18th May 20169:52 amRNSHolding(s) in Company
11th May 201610:15 amRNSHolding(s) in Company
5th May 201610:55 amRNSHolding(s) in Company
3rd May 20167:00 amRNSAppointment of Director
29th Apr 20167:00 amRNSNotice of Results, Q1 update, director holding
27th Apr 20167:00 amRNSAIM Disclosure Update
8th Apr 20169:27 amRNSHolding(s) in Company
5th Apr 201612:15 pmRNSHolding(s) in Company
31st Mar 20165:30 pmRNSTotal Voting Rights
22nd Mar 20167:00 amRNSCompletion of Acquisition, Issue of Equity, TVR
4th Mar 20165:23 pmRNSGrant of Options
4th Mar 20169:07 amRNSNew CEO of Dewynters and Acquisition
1st Mar 20167:00 amRNSTotal Voting Rights
29th Feb 20167:00 amRNSTrading Statement
15th Feb 20163:10 pmRNSDirectorate Change
10th Feb 20169:37 amRNSHolding(s) in Company
8th Feb 20164:15 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 201610:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.